Last Updated: 14 Oct 2024
Executive Summary
Bullfrog AI Holdings, Inc. (BFRG) is a digital biopharmaceutical company utilizing AI/ML to analyze data sets in medicine and healthcare. Despite a recent decline in quarterly revenue and earnings, the company has a strong balance sheet and is well-positioned for future growth. The latest stock price of $2.7 represents a significant discount to the company's intrinsic value.
Company Overview
Bullfrog AI is headquartered in Gaithersburg, Maryland, and focuses on developing AI-driven solutions for drug discovery, clinical development, and patient care. The company has a team of experienced scientists, engineers, and healthcare professionals.
Fundamental Analysis
Revenue: BFRG's revenue has grown rapidly in recent years, reaching $65,000 in the latest quarter. However, the company experienced a 1% decline in revenue year-over-year.
Earnings: The company has yet to turn a profit, with a trailing twelve-month EPS of -$0.84.
Balance Sheet: BFRG has a strong balance sheet with $13.5 million in cash and equivalents and no long-term debt.
Valuation: Based on the company's revenue growth potential, strong balance sheet, and discounted cash flow analysis, BFRG is undervalued at the current stock price.
Technical Analysis
Trend: BFRG's stock price is in a downtrend, with the 50-day and 200-day moving averages acting as resistance.
Support and Resistance: The stock has found support at $2.50 and resistance at $3.00.
Momentum: The stock's momentum indicators are neutral, suggesting a potential reversal in the downtrend.
Short Term Outlook
In the short term, BFRG's stock price is likely to remain range-bound between $2.50 and $3.00. The company's upcoming earnings report will be a key catalyst for the stock price.
Long Term Outlook
In the long term, BFRG has the potential to be a high-growth company. The company's AI/ML technology has the potential to revolutionize the healthcare industry. If BFRG can successfully commercialize its products, the stock price could rise significantly.
Analyst Recommendations
Analysts are generally bullish on BFRG's long-term prospects. However, they recommend investors wait for a more favorable entry point before buying the stock.
